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Abstract
The nervous system plays an important role in the regulation of epithelial homeostasis and has 
also been postulated to play a role in tumorigenesis. We provide evidence that proper innervation 
is critical at all stages of gastric tumorigenesis. In three separate mouse models of gastric cancer, 
surgical or pharmacological denervation of the stomach (bilateral or unilateral truncal vagotomy, 
or local injection of botulinum toxin type A) markedly reduced tumor incidence and progression, 
but only in the denervated portion of the stomach. Vagotomy or botulinum toxin type A treatment 
also enhanced the therapeutic effects of systemic chemotherapy and prolonged survival. 
Denervation-induced suppression of tumorigenesis was associated with inhibition of Wnt 
signaling and suppression of stem cell expansion. In gastric organoid cultures, neurons stimulated 
growth in a Wnt-mediated fashion through cholinergic signaling. Furthermore, pharmacological 
inhibition or genetic knockout of the muscarinic acetylcholine M3 receptor suppressed gastric 
tumorigenesis. In gastric cancer patients, tumor stage correlated with neural density and activated 
Wnt signaling, whereas vagotomy reduced the risk of gastric cancer. Together, our findings 
suggest that vagal innervation contributes to gastric tumorigenesis via M3 receptor–mediated Wnt 
signaling in the stem cells, and that denervation might represent a feasible strategy for the control 
of gastric cancer.
INTRODUCTION
The nervous system regulates epithelial homeostasis in different ways, and this regulation by 
the nervous system partly involves modulation of stem and progenitor cells (1, 2). There is 
also crosstalk between tumor cells and nerves, such that tumors induce active neurogenesis, 
resulting in increased neuronal density in preneoplastic and neoplastic tissues (3–6). In 
addition, activation of muscarinic receptors has been shown to promote cell transformation 
and cancer progression (3–6). A recent study demonstrated that prostate tumors are 
infiltrated by autonomic nerves contributing to cancer development and dissemination (7). 
Given the potential ability of nerves to influence gut stem and progenitor cells, and the 
prevailing notion that persistently elevated gut epithelial proliferation predisposes to cancer 
formation, it is believed that axonal reflexes could also modulate the conversion of stem or 
progenitor cells into cancer cells (8, 9).
Gastric cancer is the fifth most common cancer and the third leading cause of cancer 
mortality worldwide, with a 5-year survival rate of less than 25% (10, 11). It has been 
demonstrated that vagotomy decreases gastric mucosal thickness and cellular proliferation 
(12, 13). An epidemiological study showed that the risk of gastric cancer [standardized 
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incidence ratio (SIR)] after vagotomy was not reduced during the first 10-year period, but 
was reduced by 50% (SIR 0.5) during the second 10-year follow-up (14, 15). Here, we 
provide evidence that proper innervation is critical for gastric tumorigenesis, and suggest 
that nerves may represent a therapeutic target for the treatment of gastric cancer.
RESULTS
Gastric lesser curvature has high vagal innervation and high incidence of tumors
In humans, there is a higher incidence of gastric cancer in the lesser (~80% of tumors) than 
the greater curvature (16, 17). We also observed this distribution in the INS-GAS mouse 
model, a genetic mouse model of spontaneous gastric cancer (18, 19), in which there was a 
similar prevalence (77%) of tumors in the lesser curvature (Fig. 1A). INS-GAS mice do not 
display obvious preneoplastic lesions until 6 months of age, but afterward, they develop 
gastric cancer through stages of atrophy, meta-plasia, and finally, dysplasia at 12 months of 
age (18, 19). Topographic analysis of vagus nerve fibers and terminals in the murine 
stomach revealed a higher density of neurons and larger ganglia in the lesser curvature 
compared to the greater curvature (Fig. 1B), correlating with the observed pattern of tumor 
formation. This possible association between the distribution of vagal nerve fibers and the 
appearance of gastric tumors in INS-GAS mice prompted us to study the role of nerves in 
gastric tumorigenesis (fig. S1 and table S1).
Surgical denervation at preneoplastic stage attenuates tumorigenesis in mouse models of 
gastric cancer
In the first set of experiments, vagotomy was performed in INS-GAS mice at 6 months of 
age. Subsequently, the effects of vagotomy were examined 6 months after surgery. One 
hundred seven INS-GAS mice were subjected to either subdiaphragmatic VTPP, UVT (fig. 
S2), sham operation, or PP. The unilateral vagotomy approach takes advantage of the fact 
that each (anterior or posterior) vagal trunk innervates only one-half of the stomach. 
Consequently, denervation of one side of the stomach does not impair the overall functional 
capacity of the stomach, leaving gastric acid output, circulating gastrin levels, and gastric 
motility unchanged (13, 20).
Six months after surgery, body weight was unchanged in either male or female mice (fig. 
S3). Tumor incidence was 17% after VTPP versus 86% after PP alone, 14% in the anterior 
side versus 76% in the posterior side after anterior UVT, and 78% in the sham-operated 
mice (Fig. 1C). Histological examination revealed the reduction of mucosal thickness after 
VTPP (compared to PP) or UVT (compared to the corresponding posterior side) (Fig. 1D 
and fig. S4), indicating successful denervation (12, 13). Pathological evaluation (21) 
revealed that vagotomy attenuated the score for dysplasia and reduced the number of 
proliferating cells (Fig. 1, E and F) and the scores for inflammation, epithelial defects, 
oxyntic atrophy, epithelial hyperplasia, pseudopyloric metaplasia, and gastric histological 
activity index (GHAI) (fig. S5, A to F).
To confirm these findings, we tested the surgical approach in two other mouse models of 
gastric cancer, namely, the carcinogen-induced [N-nitroso-N-methylurea (MNU)] (22) and 
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the Helicobacter pylori (Hp)–infected H+/K+–ATPase (adenosine triphosphatase)– IL-1β 
(interleukin-1β) mouse models (23). In the MNU model, VTPP performed 1 week after 
completion of MNU treatment inhibited tumor development at 13 months of age (Fig. 1, G 
and H). Infection of H+/K+–ATPase–IL-1β mice with Hp accelerated gastric tumorigenesis, 
resembling Hp-related atrophy-metaplasia-dysplasia sequence in humans. UVT performed 
8.5 months after Hp infection (at 12 months of age) reduced tumor size and number of 
proliferating cells in the denervated side of the stomach at 18 months of age (Fig. 1, I and J). 
Thus, the findings from these three independent models demonstrate the importance of 
functional innervation in gastric tumorigenesis.
Pharmacological denervation at an early preneoplastic stage attenuates gastric 
tumorigenesis
To prove that the effects of surgical denervation were primarily local (acting at vagus nerve 
terminals within the gastric mucosa), unilateral injection of botulinum toxin A (Botox) into 
the gastric wall was performed in INS-GAS mice at 6 months of age. Botox enters into the 
axon terminal through vesicle internalization and cleaves synaptosomal-associated protein 
25, leading to impaired exocytosis of neurotransmitters, including acetylcholine (24). Botox 
was injected subserosally along the greater curvature in the anterior side of the stomach (Fig. 
1K). Six months later, tumor size, score for dysplasia, and number of proliferating cells were 
markedly reduced in the anterior wall compared with the posterior side of the stomach (Fig. 
1, L to N). Moreover, these changes were associated with attenuated scores for 
inflammation, epithelial defects, atrophy, hyperplasia, pseudopyloric metaplasia, and GHAI 
(fig. S6, A and B). Hence, these findings confirm an important role of local signaling from 
vagus nerve endings in early gastric tumorigenesis.
Surgical or pharmacological denervation attenuates gastric tumor progression
Because vagotomy or Botox treatment had a protective effect at preneoplastic stages, we 
next examined whether gastric denervation could also inhibit tumor progression at later 
stages. INS-GAS mice at 8, 10, or 12 months of age were subjected to anterior UVT and 
euthanized at 18 months of age. In these mice, the tumors were smaller with less severe 
dysplasia in the anterior side compared to the posterior side of the stomach, suggesting that 
denervation inhibits tumor progression in mice with established neoplastic changes (Fig. 2, 
A to C).
Whereas the average life span of wild-type FVB/N mice is well over 24 months, the survival 
of INS-GAS mice at 18 months of age was 53% (16 of 30 mice). Attenuation of tumor 
burden by UVT improved the 18-month survival when compared to age-matched INS-GAS 
mice: 71% when UVT was performed at 8 months, 64% when performed at 10 months, and 
67% when performed at 12 months, respectively (Fig. 2D). Next, INS-GAS mice at 12 
months of age were subjected to vehicle or Botox treatment unilaterally or bilaterally, with 
or without UVT. The tumor cell proliferation was reduced in the anterior side of the stomach 
where Botox was injected, when compared to the posterior side or vehicle-treated anterior 
side (Fig. 2E). The combination of UVT and Botox did not further reduce cellular 
proliferation, indicating that vagotomy and Botox likely act through the same mechanism. 
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These results further suggest that surgical or pharmacological denervation inhibits gastric 
cancer progression even when applied at later stages of gastric tumorigenesis.
Denervation enhances the effect of chemotherapy in the treatment of gastric cancer
Next, we examined whether denervation could enhance the effects of systemic 
chemotherapy in gastric cancer. INS-GAS mice at 12 to 14 months of age received systemic 
administration of 5-FU + oxaliplatin or saline along with unilateral Botox treatment or UVT. 
The experiment was designed such that the nondenervated half of the stomach in each 
animal served as an internal control, either a chemotherapy-only control (the posterior side 
of the stomach in two of the groups received chemotherapy alone) or an untreated control. 
An additional group of INS-GAS mice was included as untreated controls. As early as 2 
months after starting treatment, tumor size was reduced in mice treated with chemotherapy, 
specifically in the denervated areas of the stomach (the anterior side) after unilateral 
vagotomy or Botox injection (Fig. 2, F and G). The combination of either Botox or UVT 
with chemotherapy increased survival compared to chemo-therapy alone (Fig. 2H). 
Together, these findings suggest that the combination of denervation and chemotherapy has 
an enhanced effect on tumor growth and survival.
Denervation inhibits gastric Wnt signaling and suppresses stem cell expansion through 
the M3 receptor
We performed gene expression profiling in INS-GAS mice versus wild-type mice, and in 
unilaterally vagotomized INS-GAS mice (UVT performed at 6 months of age). Comparison 
between INS-GAS mice and wild-type mice showed up-regulation of the Wnt signaling 
pathway in INS-GAS mice (fig. S7). Comparison between the vagotomized anterior and the 
untreated posterior side of the same stomach revealed many differentially expressed KEGG 
pathways, including those involved in gastric acid secretion, mitogen-activated protein 
kinase signaling, cell cycle, apoptosis, autophagy, vascular endothelial growth factor 
signaling, and actin cytoskeleton (fig. S8). The Wnt and Notch signaling pathways were 
markedly inhibited in the vagotomized side [validated by quantitative reverse transcription 
polymerase chain reaction (qRT-PCR) arrays] (Fig. 3 and fig. S9). The inhibition of Wnt 
signaling was persistent at 2, 6, 8, and 10 months after vagotomy. Inflammation-related 
pathways, including T cell receptor signaling, natural killer cell–mediated cytotoxicity, 
leukocyte transendothelial migration, and chemokine signaling, were activated at 2 months, 
but then inhibited at 4 and 6 months after vagotomy, whereas Toll-like receptor signaling 
was inhibited at all the time points (Fig. 4A).
The Wnt signaling pathway is a major regulator of gastrointestinal stem cells and 
tumorigenesis (25, 26). CD44 is a known target of the Wnt signaling pathway (27) and has 
been shown to label a cancer-initiating cell population (28). Lgr5 is a marker of gastric stem 
cells in normal as well as cancer tissues, and also a target of the Wnt signaling pathway (29). 
Either vagotomy (VTPP and UVT) or Botox treatment induced down-regulation of CD44 
(and CD44v6) in the gastric mucosa of INS-GAS mice, although the combination of 
vagotomy and Botox did not lead to a further decrease in CD44 expression (Fig. 4, B and C, 
and figs. S10 and S11). Vagotomy also reduced the expression of Wnt target genes, such as 
Cyclin D1, Axin2, Myc, Lgr5, and Cd44, in MNU-treated mice (Fig. 4D). The number of 
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cells with nuclear translocation of β-catenin and the number of Lgr5+ cells in MNU-treated 
mice were reduced after vagotomy (Fig. 4, E and F). These results suggest that disruption of 
neuronal signaling inhibits Wnt signaling and thereby stem cell expansion, resulting in the 
suppression of tumor development in both INS-GAS and MNU mouse models.
Wnt signaling is also known to be involved in tumor regeneration (30). We have established 
a mouse model of tumor regeneration through topical application of acetic acid in INS-GAS 
mice (31). In this model, vagotomy delayed tumor regeneration in the denervated side of the 
stomach (fig. S12).
We next examined whether vagotomy down-regulated Lgr5 expression via the muscarinic 
acetylcholine receptors. Gastric epithelial cells from Lgr5-GFP mice were sorted on the 
basis of green fluorescent protein (GFP) expression. Afterward, gene expression of the 
muscarinic acetylcholine receptors was tested in Lgr5-negative, Lgr5-low, and Lgr5-high 
cell populations (Fig. 5A). We found that there was coexpression of Lgr5 and Chrm3, the 
gene encoding muscarinic acetylcho-line receptor 3 (M3R), in the sorted cells from Lgr5-
GFP mouse stomach, but other subtypes of muscarinic receptor were little expressed in 
those cells (Fig. 5, B and C), suggesting that Lgr5+ stem cell function may be modulated by 
M3R signaling. To investigate the involvement of M3 receptors in gastric tumorigenesis, we 
treated INS-GAS mice by continuous infusion of the specific M3 receptor antagonist, 
darifenacin (32), in combination with chemotherapy. Using an experimental design similar 
to that of the Botox and vagotomy experiment, we found that the combination of darifenacin 
and chemotherapy reduced cellular proliferation of the tumors (Fig. 5D). Furthermore, we 
analyzed the Wnt signaling pathway in M3KO versus wild-type mice and found that several 
key genes, including one encoding β-catenin, were down-regulated (fig. S13). We then 
exposed M3KO and wild-type mice to MNU treatment. At 7.5 months after MNU treatment 
(11 months of age), M3KO mice had less tumor induction (57.1% versus 100%) and smaller 
tumor size when compared to wild-type controls (Fig. 5, E and F). Thus, the vagus nerve 
regulates gastric tumorigenesis at least in part through M3 receptor–mediated Wnt signaling, 
which is operative in Lgr5+ stem cells.
Neurons activate Wnt signaling in gastric stem cells through M3 receptor
To demonstrate the potential regulatory role of nerves in the maintenance of gastric 
epithelium, we used an established in vitro culture system for gastric organoids (9). Primary 
neurons were isolated from murine spinal cord or the enteric nervous system of guinea pigs, 
and cocultured with gastric glands (9, 33, 34). In culture, neurons showed outgrowth of 
neurites and evidence of direct contact with the gastric organoids (Fig. 6, A to C). 
Furthermore, coculture with neurons markedly promoted gastric organoid growth (Fig. 6, D 
and E). The addition of either Botox or scopolamine (an unspecific muscarinic receptor 
antagonist) inhibited this stimulatory effect (Fig. 6, D and E), whereas pilocarpine (an 
unspecific muscarinic receptor agonist) stimulated organoid growth (Fig. 6F). Pilocarpine 
caused up-regulation of the gastric stem cell markers and Wnt target genes Lgr5, Cd44, and 
Sox9 (9) in a dose-dependent manner. However, in gastric organoids of M3KO mice, 
pilocarpine showed no effects on the expression of these genes (Fig. 6G), highlighting the 
importance of the M3 receptor for stem cell expansion. Furthermore, coculture with neurons 
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could substitute for Wnt3a in gastric organoid cultures that are otherwise strictly dependent 
on addition of Wnt ligands (35) (Fig. 6H), confirming the ability of cholinergic signaling to 
induce ligand-independent Wnt signaling in this in vitro system.
Gastric cancer patients display dysregulation of Wnt signaling and innervation in the 
tumors
To further investigate the involvement of Wnt signaling, innervation, and gastric cancer 
progression in humans, we evaluated three separate cohort studies of gastric cancer patients 
(table S2). In tumors from 17 primary gastric cancer patients, Wnt signaling, neurotrophin 
signaling, and axonal guidance pathways (along with other pathways) were activated in 
cancerous tissue when compared to adjacent noncancerous tissue (Fig. 7 and fig. S14). In 
another group of 120 primary gastric cancers, neuronal density was correlated with more 
advanced tumor stages (Fig. 8, A to C). A similar increase in neuronal density was 
confirmed in tumors of mice treated with MNU (Fig. 8, D to F). In the third cohort of 37 
patients, who developed gastric stump cancer after distal gastrectomy with or without 
vagotomy, 35% (13 of 37) of patients had undergone vagotomy. Of those 13 patients, only 1 
had a tumor in the posterior wall and none had tumors in the anterior wall. In the 24 patients 
without vagotomy, tumors were observed in both anterior and posterior walls (fig. S15).
DISCUSSION
The results of the present study, using three independent mouse models of gastric cancer, 
demonstrate that either surgical or pharmacological denervation suppresses gastric 
tumorigenesis. The effect takes place primarily on terminal and intramucosal vagal 
branches, as shown by the response to unilateral vagotomy and localized Botox injection. 
Denervation therapy was effective in both early preneoplasia and late neoplasia/dysplasia, 
and it enhanced the effect of chemotherapy and prolonged survival in mice with advanced 
tumors. Gene expression and immunohistochemical analysis of stem cell markers, along 
with the in vitro gastric organoid test, revealed that cholinergic nerves directly modulate 
epithelial stem cells through activation of Wnt signaling via the M3 receptor. Analysis of 
human patients with gastric cancer also showed correlations between neural pathways and 
Wnt signaling and increased innervation in more advanced tumors, with decreased tumor 
risk in vagotomized stomach.
In contrast to our current results, previous vagotomy studies in rat models of chemically 
induced gastric cancer did not reveal an inhibitory effect (12, 36, 37). This is likely due to 
the earlier approach of bilateral vagotomy without pyloroplasty, which delayed gastric 
emptying and therefore increased the exposure time of orally administered chemical 
carcinogens on the gastric mucosa. To ensure that dose and time of MNU exposure were 
equalized in all the groups and to prevent retention of gastric contents, we performed 
bilateral vagotomy with pyloroplasty or PP (as control) after completion of the MNU dosing 
protocol, allowing analysis of the specific effects of the vagus nerve on the gastric mucosa. 
Thus, we found that vagotomy inhibited gastric tumorigenesis in the MNU model. The data 
from two different genetically engineered mouse models of gastric cancer further established 
the inhibitory effect of denervation against gastric tumorigenesis. Given the limited 
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availability of metastatic models of gastric cancer, the effect of denervation in metastatic 
lymph nodes or other organs remains unclear and needs to be further investigated in suitable 
models.
Previous studies suggested that nerves contribute to the normal stem cell niche (1, 2, 38), 
and a recent report has linked sympathetic nerves to prostate cancer progression (7). 
However, the stomach differs from other solid organs in that its autonomic innervation is 
largely parasym-pathetic in nature, and cholinergic nerves have been shown to regulate 
gastrointestinal proliferation (39). The present study demonstrated that Lgr5+ gastric stem 
cells express the M3 receptor, and that Wnt signaling in those cells is directly activated by 
cholinergic vagus stimulation, resulting in epithelial proliferation and stem cell expansion. 
Gastrointestinal stem cells are supported by a number of niche cells including Paneth cells, 
mesenchymal stem cells, myofibroblasts, smooth muscle cells, lymph and vascular 
endothelial cells, and bone marrow–derived stromal cells (40–42). Here, we identified 
nerves regulating gastric stem cell expansion during the tumorigenesis.
The vagus nerve has been shown to stimulate cell proliferation in the brain, liver, and 
stomach through the M3 receptor (43–45). Furthermore, activation of muscarinic receptors 
in cancer cells leads to enhanced Wnt signaling independent of Wnt ligands (46), and M3 
receptor signaling has been implicated in the pathogenesis of intestinal neoplasia (6, 47, 48). 
Consistent with those findings, the present study demonstrates that genetic knockout or 
pharmacological inhibition of M3 receptor suppresses gastric tumor progression, pointing to 
the M3 receptor as a potential target for gastric cancer therapy. The M3 receptor antagonist 
darifenacin is already in clinical use for overactive urinary bladder (49) and has been shown 
to inhibit growth of small cell lung cancer xenografts (50). Given that chemotherapeutic 
agents and darifenacin appear to show cooperative effects, M3 receptor–targeting therapy 
combined with chemo-therapy in unresectable gastric cancer patients could be considered in 
future trials, although further studies are needed to evaluate the safety and long-term effects 
of those regimens.
Canonical Wnt signaling controls epithelial homeostasis in the intestine and the stomach, 
and is thought to play a role in a subset of gastric cancers (9, 51). Here, we have shown that 
Wnt signaling is up-regulated in the tumorigenic stomach and is down-regulated after 
vagotomy, suggesting that vagus nerve is a critical regulator of Wnt signaling in gastric 
tumorigenesis. Furthermore, gastric Wnt signaling was down-regulated in M3KO mice, 
which were resistant to MNU-induced tumorigenesis. In addition, inhibition of Notch 
signaling was also observed after vagotomy, which is in line with both Wnt and Notch 
signaling promoting the initiation of intestinal tumors (52, 53). Therefore, therapeutic 
modulation of Wnt signaling blockade using tankyrase inhibitors could also be considered, 
although the dose-limiting toxicity of available agents has restricted their clinical use to this 
point (54). Finally, we cannot exclude a role for additional pathways (for example, 
prostaglandin E2 pathway) that may be modulated by nerves in gastric tumorigenesis.
Our finding that nerves play an important role in cancer initiation and progression highlights 
a component of the tumor microenvironment contributing to the cancer stem cell niche. The 
data strongly support the notion that denervation and cholinergic antagonism, in 
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combination with other therapies, could represent a viable approach for the treatment of 
gastric cancer and possibly other solid malignancies.
MATERIALS AND METHODS
We used 581 mice divided into 14 experimental groups. In each experiment, mice were 
randomly divided into different subgroups (fig. S1 and table S1). INS-GAS mice with 
spontaneous gastric cancer were used as previously described (18, 19). Denervation was 
achieved by subdiaphragmatic bilateral truncal vagotomy, unilateral vagotomy, or Botox 
local injection. The tumor prevalence/incidence, tumor size, tumor regeneration, 
pathological changes, gene expression profiles, and immunohisto-chemical biomarkers were 
examined after denervation. In vitro gastric organoid culture was performed as described 
previously (9). We also performed three cohort studies of human primary gastric cancer and 
gastric stump cancer, as well as gene expression profiling and KEGG pathway analysis. All 
studies and procedures involving animals and hu man subjects were approved by the 
Norwegian National Animal Research Authority, the Columbia University Institutional 
Animal Care and Use Committee, Gifu University, and the National Cancer Center Hospital 
East, Japan. Statistical comparisons were performed between experimental groups, between 
the anterior and posterior sides of the stomachs, and between groups of patients. See the 
Supplementary Materials for the complete Materials and Methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Denervation attenuates tumorigenesis at the preneoplastic stage in mouse models of 
gastric cancer
(A) Tumor prevalence at the lesser curvature (LC) and greater curvature (GC) of the 
stomach of INS-GAS mice. (B) Images of carbocyanine dye (DiI)–labeled vagal terminals in 
an adult mouse stomach. A montage of a low-power image showing the lesser curvature and 
greater curvature of the gastric wall (top scale bar, 2.0 μm), and higher-power images of 
lesser curvature (middle) and greater curvature (bottom) show a higher density of vagal 
innervation in lesser curvature than in greater curvature (89 and 54% of the visual field, 
estimated by point counting method) (middle and bottom scale bars, 72 μm). (C) Tumor 
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incidence at 12 months of age in INSGAS mice that underwent sham operation (Sham), 
pyloroplasty alone (PP), bilateral vagotomy with pyloroplasty (VTPP), or anterior unilateral 
vagotomy (UVT) (A, anterior; P, posterior side of the stomachs) at 6 months of age. ***P = 
4.9 × 10−7 (VTPP versus PP), P = 1.32 × 10−6 [UVT(A) versus UVT(P)] (Fisher's exact 
test). (D) Representative microphotographs of histopathological appearance of the anterior 
and posterior sides of the stomach from INS-GAS mice (at 12 months of age) that 
underwent sham, PP, VTPP, and UVT at 6 months of age. Scale bars, 100 μm. (E) 
Pathological score for dysplasia. Means ± SEM. Comparisons between anterior and 
posterior sides were performed by paired t test within sham (n = 27) and UVT (n = 30), or 
by Tukey test between PP (n = 25) and VTPP (n = 25). ***P = 5.31 × 10−5 (UVT), P = 
0.0001 or 0.00006 (PP and VTPP, anterior or posterior side, respectively). ns, not significant 
(P = 0.987). (F) Number of proliferating cells. Means ± SEM. Comparisons between 
anterior and posterior sides were performed by paired t test within sham (n = 27) and UVT 
(n = 30), or by Tukey test between PP (n = 25) and VTPP (n = 25). ***P = 5.77 × 10−3 
(UVT), P = 1.90 × 10−4 (anterior), and P = 1.49 × 10−3 (posterior) between PP and VTPP. 
ns, not significant (P = 0.229). (G) Representative photographs showing gross appearance of 
stomachs opened along the greater curvature and corresponding microphotographs of 
histopathological appearance of the stomachs (antrum) from mice treated with MNU + PP or 
MNU + VTPP. Scale bars, 100 μm. (H) Volume density of tumor (measured by point 
counting method). Means ± SEM. Student's t test was used to compare between MNU + PP 
(n = 11) and MNU + VTPP (n = 9). (I) Representative photograph showing gross 
appearance of gastric tumors (indicated by dashed line) in a stomach opened along the 
greater curvature from an Hp-infected H+/K+– ATPase–IL-1β mouse, which underwent 
UVT in the anterior side (indicated by asterisk).(J)Number of proliferating cells in Hp-
infectedH+/K+–ATPase–IL-1β mouse stomachs subjected to UVT in the anterior side. 
Means ± SEM. ***P = 0.00006 (Student's t test). ns, not significant (P = 0.120) between 
sham (n = 12) and UVT (n = 12) in the anterior and the posterior sides. (K) Photographs 
showing the Botox injection procedure (upper left), gross appearance of Botox-injected 
stomach after 6 months (A, anterior where Botox was injected; P, posterior) (upper right), 
and representative microphotographs of histopathological appearance of anterior (lower left) 
and posterior (lower right) stomach (corpus). Red arrow, injection site. Scale bars, 100 μm. 
(L to N) Volume density of tumor, pathological score for dysplasia, and number of 
proliferating cells after anterior Botox injection. Means ± SEM (n = 16). ***P = 2.75 × 
10−11 (L), P = 0.01 (M), or P = 0.001 (N) between the anterior and posterior sides of the 
stomach (paired t test).
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Fig. 2. Denervation attenuates gastric tumor progression in mice
(A) Gross appearance of mouse stomachs at 18 months of age and representative micro-
photographs of the histopatho-logical appearance of the corpus region of the anterior and 
posterior sides of the stomach from age-matchedINS-GAS mice (Control) and mice that 
underwent anterior UVT at 8 or 12 months of age. Scale bars, 100 μm. Red arrows, 
vagotomy side. (B) Volume density of tumor. Means ± SEM. Paired t test between the 
anterior and the posterior sides of the stomach: P = 0.589 (n = 21, Control), P = 2.56 × 10−5 
(n = 17, UVT at 8months ofage),P=2.17×10−4 (n = 14, UVT at 10 months), P = 0.055 (n = 
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12, UVT at 12 months). (C)Pathological score for dysplasia. Means ± SEM. Paired t test 
between the anterior and the posterior sides of the stomach: P = 0.38 (n = 21, Control), P = 
0.002 (n = 17, UVT at 8 months of age), P=0.047(n=14,UVT at 10 months), 
P=0.018(n=12,UVT at 12 months). (D) Kaplan-Meier curves showing survival of INS-GAS 
mice that underwentUVTat8(red),10(green), or 12 months of age (blue), or of age-matched 
INS-GAS mice (Control) (black). P = 0.01 between control and UVT groups at 8 months. 
(E) Proliferating cells in the anterior and posterior mucosa of the stomach of INS-GAS mice 
at 2 months after vagotomy and/or Botox injection. Means ± SEM. Paired t test was used to 
compare the anterior and posterior sides of the stomach. P = 0.291 (n = 6, Vehicle), P = 
0.007 [n = 6, unilateral anterior Botox (UB)], P = 0.595 [n = 7, bilateral Botox (BB)], P = 
0.326 [n = 7, bilateral Botox plus anterior UVT (BB + UVT)], P = 0.0007 (Vehicle anterior 
versus UB anterior, Dunnett's test). (F) Volume density of tumor in INS-GAS mice 
subjected to saline (intraperitoneally) (Control), UB + saline (intraperitoneally), UB + 5-
fluorouracil (5-FU) + oxaliplatin (OXP) (intra peritoneally), or UVT + 5-FU + OXP 
(intraperitoneally). Means ± SEM. Paired t test was used to compare the anterior and 
posterior sides of the stomach. P = 0.172 (n = 10, Control), P = 0.200 (n = 10, UB + saline), 
P = 0.0004 (n = 24, UB + 5-FU + OXP), P = 0.006 (n = 16, UVT + 5-FU + OXP). (G) 
Gross appearance of representative stomachs from INS-GAS mice subjected to 5-FU + OXP 
with UB or UVT (reduced tumor burden indicated by arrows). (H) Kaplan-Meier curves 
showing survival of INS-GAS mice that underwent sham operation and 5-FU + OXP 
treatment (black), UB and 5-FU + OXP (red), or anterior UVT and 5-FU + OXP (blue). *P 
= 0.041, **P = 0.0069.
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Fig. 3. Denervation leads to inhibition of Wnt signaling in the mouse model of gastric cancer
Gene expression of Wnt signaling pathway (determined by qRT-PCR array analysis) in 
vagotomized anterior stomach of INS-GAS mice at 12 months of age (6 months UVT). Log2 
fold changes of expressed genes in comparison with the posterior side of the same stomach 
are shown. Red, down-regulation; blue, up-regulation.
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Fig. 4. Denervation alters inflammation-related signaling and suppresses stem cell expansion in 
mouse models of gastric cancer
(A) Time course of five signaling pathways determined by microarray analysis in the 
anterior side of the stomach at 2 (blue), 4 (green), and 6 (red) months after anterior UVT 
compared with the posterior side of the stomach in INSGAS mice. Total net accumulated 
perturbation (expressed as tA score): −4 to 6. tA score > 0: activation; tA score < 0: 
inhibition. (B) Numbers of CD44+ cells in the anterior and the posterior sides of the stomach 
of INS-GAS mice at 6 months after surgery. Means ± SEM. P = 0.037 (n = 27, paired t test) 
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between the anterior and the posterior sides in sham operation (Sham), P = 1.00 × 10−6 or P 
= 6.00 × 10−6 (n = 25, Dunnett's test) between PP and VTPP (anterior and posterior sides, 
respectively), and P = 1.74 × 10−3 (n = 30, paired t test) between the anterior and the 
posterior sides within anterior UVT. (C) Numbers of CD44-immunoreactive cells (CD44) 
and CD44v6-immunoreactive cells (CD44v6) in the anterior and the posterior sides of the 
stomach of INSGAS mice at 6 months after Botox injection. Means ± SEM. P = 0.034 and P 
= 0.021, respectively (n = 16, paired t test) between the anterior and the posterior sides of 
the stomach. (D) Relative gene expression of Cyclin D1, Axin2, Myc, Lgr5, and Cd44 in the 
gastric tumors of sham-operated or VTPP-treated mice 36 weeks after MNU treatment (n = 
4 per group). Means ± SEM. P = 0.04 (Cyclin D1), 0.04 (Axin2), 0.03 (Myc), 0.001 (Lgr5), 
and 0.01 (Cd44) (Student's t test). (E) Number of cells showing nuclear β-catenin 
accumulation in the gastric tumors of PP- or VTPP-treated mice 36 weeks after MNU 
treatment (n = 4 per group). Means ± SEM. P = 7.00 × 10−6 (Student's t test). Representative 
immunohistochemical microphotographs are shown below. Scale bars, 40 μm. (F) Number 
of Lgr5+ cells in the stomachs of PP- or VTPP-treated mice 6 weeks after MNU treatment (n 
= 5 per group). Means ± SEM. P = 4.00 × 10−6 (Student's t test). Representative Lgr5-GFP+ 
microphotographs are shown below. Scale bars, 20 μm.
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Fig. 5. M3 receptor signaling in gastric stem cells regulates tumorigenesis in mouse models of 
gastric cancer
(A) Representative fluorescence-activated cell sorting gating showing forward scatter (FSC) 
and Lgr5-GFP expression. (B and C) Relative gene expression of Lgr5 and muscarinic 
receptors (Chrm1 to Chrm5) in sorted Lgr5-negative, Lgr5-low, and Lgr5-high populations. 
Means ± SEM (n = 4). (D) Number of proliferating cells in the tumors of INS-GAS mice 
treated with saline (Control, n = 19), M3 receptor antagonist darifenacin (M3R, n = 15), 5-
FU + oxaliplatin (Chemo, n = 12), or combination of 5-FU + oxaliplatin + darifenacin (M3R 
+ Chemo, n = 8), respectively. Means ± SEM. P values were calculated by Dunnett's test. 
(E) Representative photographs showing gross appearance of stomachs opened along the 
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greater curvature from wild-type (WT) or M3 receptor knockout mice (M3KO) treated with 
MNU. (F) Volume density of tumor in the stomachs of MNU-treated WT (n = 13) versus 
MNU-treated M3KO mice (n = 7). Means ± SEM (Student's t test).
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Fig. 6. Neurons activate Wnt signaling in gastric stem cells through the M3 receptor
(A to C) Representative microphotographs showing gastric organoids along with neurite 
outgrowth. (A) Guinea pig enteric neuron (green arrowhead) with gastric organoids (red 
asterisks). Scale bar, 5 μm. (B) Three-dimensional images (low and high magnifications) 
obtained by two-photon microscopy of gastric organoids (red) derived from an ACTB-
tdTomato mouse and neurons (green) derived from a UBC-GFP mouse. Scale bars, 20 μm 
(left) and 5 μm (right). In (C), fluorescent images show gastric organoids (red) alone (left, 
Control) or cocultured with neurons (green) (right, Neuron) at day 4. Scale bars, 10 μm. (D) 
Relative number of organoids after 72 hours in control, neuron coculture, control plus 
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Botox, or neuron coculture plus Botox. Means ± SEM. n = 4 per group. **P = 0.002 
(Student's t test). ns, not significant compared to control. (E) Relative number of organoids 
after 72 hours in control or neuron coculture with or without scopolamine (SCOP) (1 μg/ml). 
Means ± SEM. n = 4 per group. **P = 0.003 (Student's t test). ns, not significant compared 
to control. (F) Relative number of organoids at day 10 with or without 100 μM pilocarpine. 
Means ± SEM. n = 4 per group. **P = 0.006 (Student's t test) between control and 
pilocarpine. (G) Relative mRNA expression for Lgr5, Cd44, and Sox9 in relation to Gapdh 
on day 7 with or without 10 or 100 μM pilocarpine in gastric organoids isolated from WT or 
M3KO mice. Means ± SEM. Student's t test between 0 μM and 10 or 100 μM pilocarpine. n 
= 4 per group. (H) Relative number of organoids at day 10 with or without neurons and/or 
Wnt3a. Means ± SEM. n = 4 per group. ns, not significant. *P = 0.030 compared to Control 
+ Wnt3a (Student's t test).
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Fig. 7. Gastric cancer patients exhibit a dysregulation of Wnt signaling
Gene expression of Wnt signaling pathway (microarray analysis) in human gastric cancer 
tissue. The graph shows log2 fold changes of expressed genes in comparison with the 
adjacent noncancerous tissue of the same stomach. Red, down-regulation; blue, up-
regulation.
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Fig. 8. PGP9.5 and peripherin may represent neural markers for gastric cancer progression
(A) Representative microphotographs showing human gastric cancer [indicated by yellow 
arrowheads, hematoxylin and eosin (H&E) staining] and PGP9.5-labeled nerve (green 
arrowhead). Scale bars, 50 μm. (B) Volume density of PGP9.5-labeled nerves in different 
levels of depth of tumor invasion [T2 (tumor invading muscularis propria) versus T3 (tumor 
penetrating subserosal connective tissue without invasion of visceral peritoneum or adjacent 
structures)] in the stage II and III gastric cancer patients. Means ± SEM (n = 120). P = 0.008 
(Student's t test). (C) Number of lymph node metastases in patients with stage II and III or 
stage IV gastric cancer that has low or high expression of PGP9.5. Means ± SEM (n = 120). 
P values were calculated by Student's t test. (D) PGP9.5- and peripherin-immunoreactive 
nerve densities in gastric mucosa of control mice (nontumor) and MNU-treated mice 
(tumor). PGP9.5 is a ubiquitin-protein hydrolase that is expressed in the neuronal cell bodies 
and axons in the central and peripheral nervous system. Peripherin is a type III intermediate 
filament protein that is expressed in peripheral and some central nervous system neurons. 
Both can be used as neuronal markers in the gut. Means ± SEM (n = 6 per group). P values 
were calculated by Student's t test. (E and F) Representative immunohistochemical 
microphotographs showing PGP9.5 and peripherin (indicated by red arrows) in the 
nontumor and tumor areas of the mouse stomachs. Scale bars, 20 μm (E) and 40 μm (F).
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